Status: Recruiting
Pembrolizumab in Treating Participants With Leukoplakia
This phase II pilot trial studies how well pembrolizumab works in treating leukoplakia. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.
Participants needed: 26
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Jonsson Comprehensive Cancer CenterUpdated: Jul 30, 2025Locations: 3
Eligibility criteria
Be willing and able to provide written informed consent/assent for the trial. [+19]
Patients with leukoplakia, erythroleukoplakia or PVL who have only mild dysplasi... [+21]